Clinical Trial

Trial Protocol ID USOR 18283_IMMU-132-06_TROPHY U-01

Trial Description

A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable
Locally Advanced/Metastatic Urothelial Cancer

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Yousuf A. Gaffar, M.D.

Disease Types

Sponsor

  • Mirati Therapeutics, Inc. PRA Health Sciences

ClinicalTrials.gov NCT ID

  • NCT03785249